20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Stevanato Group SpA (STVN) operates in the MEDICAL INSTRUMENTS & SUPPLIES industry and is headquartered in Piombino Dese, Italy with about 6,010 employees. Its market capitalization is roughly $6 billion. In the fiscal year ended 2025-12-31, STVN reported €1.1B in revenue and €134M in net income.
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.
Interactive charts & full statements → Open the STVN valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | €1.2B | €1.1B | €1.1B | €1.1B | €984M | €844M | €662M | €537M |
| Gross Profit | €356M | €330M | €302M | €340M | €320M | €265M | €194M | €138M |
| Gross Margin % | 29.2% | 29.0% | 27.4% | 31.3% | 32.5% | 31.4% | 29.3% | 25.7% |
| Operating Income (EBIT) | €197M | €183M | €161M | €201M | €192M | €162M | €103M | €62M |
| Operating Margin % | 16.1% | 16.1% | 14.6% | 18.5% | 19.6% | 19.2% | 15.6% | 11.6% |
| Net Income | €134M | €134M | €118M | €146M | €143M | €134M | €79M | €39M |
| Net Margin % | 11.0% | 11.8% | 10.7% | 13.4% | 14.5% | 15.9% | 11.9% | 7.3% |
| EBITDA | €272M | €289M | €248M | €272M | €256M | €227M | €156M | €107M |
| Earnings Per Share (EPS) | €0.49 | €0.49 | €0.43 | €0.55 | €0.54 | €0.51 | €0.30 | €0.15 |
| Shares Outstanding (M) | 273M | 273M | 273M | 265M | 265M | 265M | 265M | 265M |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | €302M | €274M | €343M | €303M | €280M | €257M | €331M | €278M |
| Gross Profit | €87M | €75M | €106M | €88M | €79M | €70M | €98M | €74M |
| Gross Margin % | 28.7% | 27.5% | 30.9% | 29.2% | 28.1% | 27.2% | 29.7% | 26.8% |
| Operating Income (EBIT) | €39M | €39M | €66M | €53M | €41M | €35M | €67M | €41M |
| Operating Margin % | 13.0% | 14.2% | 19.2% | 17.4% | 14.8% | 13.5% | 20.2% | 14.8% |
| Net Income | €23M | €28M | €47M | €36M | €30M | €27M | €48M | €30M |
| Net Margin % | 7.6% | 10.2% | 13.7% | 11.9% | 10.6% | 10.3% | 14.6% | 10.8% |
| EBITDA | €40M | €65M | €94M | €73M | €62M | €57M | €87M | €103M |
| Earnings Per Share (EPS) | €0.08 | €0.10 | €0.17 | €0.13 | €0.11 | €0.10 | €0.18 | €0.11 |
| Shares Outstanding (M) | 273M | 273M | 273M | 273M | 273M | 273M | 273M | 273M |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | €247M | €275M | €156M | €105M | €103M | €133M | €156M | €43M |
| Capital Expenditures (CapEx) | €273M | €253M | €314M | €442M | €243M | €113M | €96M | €74M |
| Free Cash Flow (FCF) | (€26M) | €21M | (€158M) | (€337M) | (€140M) | €20M | €60M | (€31M) |
| FCF Margin % | -2.1% | 1.9% | -14.3% | -31.0% | -14.2% | 2.4% | 9.0% | -5.8% |
| Dividends Paid | — | €14M | €14M | €14M | €14M | €11M | €9M | €6M |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | €32M | €75M | €92M | €47M | €45M | €100M | €44M | €112M |
| Capital Expenditures (CapEx) | €66M | €71M | €88M | €48M | €60M | €72M | €89M | €222M |
| Free Cash Flow (FCF) | (€34M) | €5M | €5M | (€1M) | (€15M) | €28M | (€45M) | (€110M) |
| FCF Margin % | -11.2% | 1.7% | 1.4% | -0.4% | -5.5% | 10.9% | -13.7% | -39.7% |
| Dividends Paid | — | — | €0M | — | — | — | €0M | €14M |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Total Assets | €2.6B | €2.5B | €2.3B | €2.1B | €1.7B | €1.4B | €968M | €882M | €782M |
| Cash & Cash Equivalents | €79M | €131M | €98M | €70M | €229M | €411M | €116M | €85M | €75M |
| Total Liabilities | €1.1B | €1.1B | €924M | €939M | €664M | €577M | €658M | €617M | €550M |
| Total Debt (Short + Long-Term) | €436M | €459M | €417M | €383M | €204M | €227M | €343M | €354M | €300M |
| Total Shareholders' Equity | €1.6B | €1.5B | €1.4B | €1.1B | €996M | €842M | €310M | €265M | €232M |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive STVN viewer.
About TickerBase · Data methodology & sources · Privacy · Terms